Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Durect Corporation (DRRX)

« Back to company index

DRRX Chatter Timeline

Stock Ticker for DRRX

Most Active Tweeters for DRRX

UserTweets
@bibeypost_stock 2
@Jaldip15 2
@AmericanBanking 2
@ConsumerFeed 1
@mmahotstuff1 1

Recent Tweets for DRRX

AmericanBanking @AmericanBanking
DURECT Co. $DRRX Expected to Post Quarterly Sales of $3.50 Million https://t.co/NC2FztYZXE #stocks
April 19th 2019, 3:04am
Jaldip15 @Jaldip15
$DRRX update from today’s meeting ?
April 17th 2019, 3:04pm
AmericanBanking @AmericanBanking
-$0.05 EPS Expected for DURECT Co. $DRRX This Quarter https://t.co/txZmUMe4sH #stocks
April 17th 2019, 2:04pm
Jaldip15 @Jaldip15
$DRRX still holding.
April 16th 2019, 10:04am
bibeypost_stock @bibeypost_stock
Durect Corporation $DRRX Sellers Increased By 0.57% Their Shorts https://t.co/KtyYtAtNsP
April 15th 2019, 6:04am
bibeypost_stock @bibeypost_stock
Durect Corp's $DRRX Sentiment is 0.89 https://t.co/ryxqVYeq9r
April 13th 2019, 2:04pm
ConsumerFeed @ConsumerFeed
DURECT Co. $DRRX Stake Lowered by Ingalls & Snyder LLC https://t.co/KxyeW8arVk
April 12th 2019, 4:04am
autisticnation1 @autisticnation1
This endogenous #exosterol could be worth billions for $drrx. It is so versatile, hardly any ae, works in low doses… https://t.co/q4Xhv7mitL
April 10th 2019, 4:04pm
4thQuarterCap @4thQuarterCap
Added to $DRRX https://t.co/HZlverYhL4
April 8th 2019, 8:04pm
LlcBillionaire @LlcBillionaire
$DRRX strong squeeze coming here
April 7th 2019, 2:04pm
mmahotstuff1 @mmahotstuff1
Durect Corporation $DRRX Could Burn Your Long Portfolio After More Shorts https://t.co/twgo9OGJMR
April 7th 2019, 10:04am
TopStockAlerts1 @TopStockAlerts1
$DRRX Setting up for a multi day run
April 3rd 2019, 2:04pm
Ultra_Calls @Ultra_Calls
$DRRX 450K block buy
April 3rd 2019, 1:04pm
TranscriptDaily @TranscriptDaily
Short Interest in DURECT Co. $DRRX Declines By 42.1% https://t.co/mqsIaYOe6u
April 2nd 2019, 1:04am
ThisLincolnian @ThisLincolnian
Zacks: Brokerages Anticipate DURECT Co. $DRRX Will Announce Earnings of -$0.05 Per Share https://t.co/AywYLRxcmJ
April 1st 2019, 7:04pm
StockNewsNow @StockNewsNow
$DRRX DURECT to Present at the H.C. Wainwright Global Life Sciences Conference and Host an Upcoming KOL call on NASH https://t.co/hcCSv2bRAs
April 1st 2019, 12:04pm
Allstocknews @Allstocknews
$DRRX DURECT to Present at the H.C. Wainwright Global Life Sciences Conference and Host an Upcoming KOL call From our Stock News Alerts App
April 1st 2019, 8:04am
bbnsnews @bbnsnews
DURECT Co. $DRRX Short Interest Update https://t.co/cBhCZDmbIT
April 1st 2019, 1:04am
LlcBillionaire @LlcBillionaire
$DRRX under the 50 MA
March 31st 2019, 3:03pm
dakotafinancial @dakotafinancial
DURECT Co. $DRRX Short Interest Down 42.1% in March https://t.co/IeU5rMXdiw
March 31st 2019, 2:03am
AmericanBanking @AmericanBanking
DURECT Co. $DRRX Short Interest Down 42.1% in March https://t.co/6IGIWZOKJt #stocks
March 31st 2019, 2:03am
bibeypost_stock @bibeypost_stock
Institutional Investor Sentiment About Durect Corp $DRRX Up https://t.co/1wUc2ffjTm
March 31st 2019, 1:03am
reurope_stock @reurope_stock
Durect Corp $DRRX Institutional Investors Sentiment Index Crashed in Q4 2018 https://t.co/LJHtXUNUCs
March 31st 2019, 1:03am
reurope_stock @reurope_stock
Durect Corporation $DRRX Just Reported Increased Shorts https://t.co/gtZgbjunr1
March 30th 2019, 4:03pm
bbnsnews @bbnsnews
DURECT Co. $DRRX Expected to Announce Earnings of -$0.05 Per Share https://t.co/z0g1yzVhjn
March 30th 2019, 1:03pm
ConsumerFeed @ConsumerFeed
$3.50 Million in Sales Expected for DURECT Co. $DRRX This Quarter https://t.co/o32Ebm1JXO
March 30th 2019, 1:03pm
4thQuarterCap @4thQuarterCap
Added to $DRRX in crockpot
March 29th 2019, 4:03pm
ZolmaxNews @ZolmaxNews
Zacks: Brokerages Expect DURECT Co. $DRRX Will Post Earnings of -$0.05 Per Share https://t.co/TuDef4cjGl
March 28th 2019, 9:03am
MaisaCorp @MaisaCorp
$DRRX Starts Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 for Non-Alcoholic Steatohepatitis
March 27th 2019, 4:03pm
LifeSciAdvisors @LifeSciAdvisors
DURECT $DRRX Announces Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 in Patients with Non-Alcoholic… https://t.co/grJL3nHzbP
March 27th 2019, 3:03pm
StockNewsNow @StockNewsNow
$DRRX DURECT Announces Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 in Patients with Non-Alcoholic… https://t.co/U5pvEFsEu9
March 27th 2019, 10:03am
newswelldone @newswelldone
$DRRX: DURECT begins enrollment in phase 1b trial of oral DUR-928: https://t.co/lnpw30l06C
March 27th 2019, 9:03am
MarketCurrents @MarketCurrents
$DRRX - DURECT begins enrollment in phase 1b trial of oral DUR-928 https://t.co/bQHhBksAcd
March 27th 2019, 9:03am
Stock_News_Now @Stock_News_Now
$DRRX: New SEC Filing for DRRX: Form 8-K (No. 0001564590-19-009470): https://t.co/kIxFh5LhPF
March 27th 2019, 9:03am
StockTexts @StockTexts
$DRRX DURECT Corporation SEC Filing: Form 8-K https://t.co/apbd4pyI2O
March 27th 2019, 9:03am
bmarckxCFA @bmarckxCFA
$DRRX DURECT Announces Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 in Patients with N...… https://t.co/EK58KBbA0c
March 27th 2019, 8:03am
ProTradersNews @ProTradersNews
$DRRX: DURECT Announces Patient Enrollment in Phase 1b Clinical Trial of …: https://t.co/aFCnVSimcp
March 27th 2019, 8:03am
Allstocknews @Allstocknews
$DRRX DURECT Announces Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 in Patients with Non-Alc From our Stock News Alerts App
March 27th 2019, 8:03am
AmericanBanking @AmericanBanking
DURECT Co. $DRRX Expected to Post Quarterly Sales of $3.50 Million https://t.co/JuovKLMBtH #stocks
March 27th 2019, 3:03am
dispatchtribune @dispatchtribune
DURECT Co. $DRRX Expected to Post Quarterly Sales of $3.50 Million https://t.co/uTbmUbunyp
March 27th 2019, 3:03am
AmericanBanking @AmericanBanking
DURECT Co. $DRRX Expected to Announce Earnings of -$0.05 Per Share https://t.co/dtVl4iEGnM #stocks
March 25th 2019, 2:03pm
registrarjourn @registrarjourn
Analysts Anticipate DURECT Co. $DRRX Will Announce Earnings of -$0.05 Per Share https://t.co/24Wst9mkjQ
March 25th 2019, 2:03pm
EnterpriseLeade @EnterpriseLeade
Analysts Anticipate DURECT Co. $DRRX Will Announce Earnings of -$0.05 Per Share https://t.co/1pYM2HBE5G
March 25th 2019, 2:03pm
biostockguru @biostockguru
$PTIE Non news re: $DRRX - it’s all about novel #alzheimer molecule - expect PR soon
March 25th 2019, 9:03am
LlcBillionaire @LlcBillionaire
$DRRX watching the 50 MA here to see if it holds https://t.co/To30hjvgrO
March 24th 2019, 7:03pm
MaisaCorp @MaisaCorp
$PTIE Pain Therapeutics Says Sent Letter To Durect Corp Pursuant To Development And License Agreement $DRRX LE… https://t.co/luXOsbKuhq
March 22nd 2019, 7:03pm
BioStocks @BioStocks
RT @TraderTexMex: $PTIE Pain Therapeutics ends development of REMOXY ER and contractual relationship with Durect Corporation $DRRX
March 22nd 2019, 7:03pm
TraderTexMex @TraderTexMex
$PTIE Pain Therapeutics ends development of REMOXY ER and contractual relationship with Durect Corporation $DRRX
March 22nd 2019, 7:03pm
confcalltran @confcalltran
Termination of a Material Definitive https://t.co/NnzhMKsPFu $DRRX
March 22nd 2019, 4:03pm
bibeypost_stock @bibeypost_stock
Durect Corporation $DRRX Could Burn Your Long Portfolio After More Shorts https://t.co/wPTBnlFOLV
March 22nd 2019, 9:03am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.